Navigation Links
Potential Lifesaver Drug Announced

Can what is done be undone? In a part answer to that adage researchers have announced the developing //of a miracle drug to treat genetic disease- those which one is born with and which usually is not correctable.

Obviously the scientific world is too thrilled for silence. The drug named as PTC124 and been worked upon by researchers from PTC Therapeutics in New Jersey and those from University of Pennsylvania and Massachusetts , is slated to be licensed for public use by 2009.

The drug which trains the crosshairs on diseases caused by faulty genes, has been so far successful on Duchenne muscular dystrophy (DMD) and cystic fibrosis. The drug is being tested on humans now after promising results on mice and researchers hope it could eventually be used to treat sufferers of around 2,000 other types of hereditary disease.

DMD is known to afflict one in 3,500 boys and is marked by weakness and muscle wasting. Children born with cystic fibrosis suffer digestion and respiratory problems and tend to die early. Both these conditions are caused by so-called "nonsense mutations" in the child's DNA meaning that the sufferer lacks a vital protein.

Accordingly, in most genetic conditions, between 5-15 per cent of cases are caused by a defect called a “nonsense mutation”.

Genes are instruction manuals for cells to make proteins, but nonsense mutations in effect introduce a command halfway through that stops production. The kind of protein disrupted determines the nature of the disease.

In Duchenne muscular dystrophy, for example, the protein necessary for normal muscle development is not made, and the fatal wasting disease is the result. In hemophilia, it is the gene for the clotting agents factor VIII or factor IX that is disrupted.

Till now no known cure for either CF or DMD and sufferers rarely live beyond their 30s. Yet now the researchers have announced that mice suffering from a form of DMD began
'"/>




Page: 1 2

Related medicine news :

1. Potential New Cancer Gene Identified
2. Lack of Smell And Its Potential Risks
3. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
4. The Potential Of Cadaver Transplantation Programme In India
5. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
6. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
7. A Protein In Yoghurt Has The Potential To Fight E. coli
8. Gold Therapy- A Potential Treatment For Autoimmune Diseases
9. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
10. Potential Benefits Of New Nanotechnology
11. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Potential Lifesaver Drug Announced

(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
...8 Eclipsys Corporation(R),(Nasdaq: ECLP ), The O...ticipating in the 10th Annual Needham Growth Stock...n New York, NY., (Logo: http://www.newscom.com/c...sted parties are invited to,listen to the presenta...
...s found eye procedure helped for at least a decade...aser surgery effectively and safely corrects sever...sts. , People with myopia, which is caused by exce...ree Americans suffers from some degree of nearsigh...
...cid boosts protein that destroys brain plaques, st...e omega-3 fatty acids found in fish oil might play...se, according to a research team at the University...fatty acid docosahexaenoic acid (DHA) increases th...
...Mich., Dec. 28 Versus,Technology, Inc. ("Versus" ... for the fiscal quarter ended October 31, 2007, co...od in 2006. Revenues for the year,ended October 31...ivery of major customer projects. Accordingly, rev...
...ponse points to ,psychological immune system, stud...News) -- When thoughts of death intrude, the human...stead, the brain instinctively moves toward happie...ved one,s death than they may have ever thought po...
...e Colonel, featured in award winning Helen Keller ... BIRMINGHAM, Ala., Dec. 28 Back in 1978, the,orig...Sanders traveled to,the Callahan Eye Foundation Ho...t and in building a then state-of-the-art,eye trea...
Other Medicine News:Health News:Eclipsys to Present at 10th Annual Needham Growth Stock Conference 2Health News:Eclipsys to Present at 10th Annual Needham Growth Stock Conference 3Health News:Laser Surgery Can Correct Nearsightedness 2Health News:Fish Oil May Help Prevent Alzheimer's 2Health News:Versus Technology Announces Fourth Quarter Results 2Health News:Versus Technology Announces Fourth Quarter Results 3Health News:Versus Technology Announces Fourth Quarter Results 4Health News:Versus Technology Announces Fourth Quarter Results 5Health News:Versus Technology Announces Fourth Quarter Results 6Health News:Versus Technology Announces Fourth Quarter Results 7Health News:Brain Turns to Positive Thoughts When Faced With Death 2Health News:Brain Turns to Positive Thoughts When Faced With Death 3Health News:Brain Turns to Positive Thoughts When Faced With Death 4Health News:Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story 2Health News:Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story 3
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 1Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 3Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 4Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 5Distrust of men doesnt stall low income mothers romantic unions 62447 1Young adults who exercise get higher IQ 10960 1Young adults who exercise get higher IQ 10960 2
...BUDAPEST, Hungary and EXTON, Pa., May 26 ViroPhar...the presentation of five abstracts relating to Cin...t the 6th Annual C1 Inhibitor Deficiency Workshop....rug Administration in October 2008 for routine pro...ks in adults and adolescents. In February 2009, Vi...
...Data Confirm Tapentadol Efficacy and Tolerability ... It is estimated that up to 30 percent of all peo...ide effects, such as nausea and vomiting. The use ...is a leading risk factor for experiencing these si...and bothersome and can have an impact on a patient...
Other Medicine Technology:Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 2Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 3Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 4Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 5Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 6Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: